BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11678801)

  • 1. Endometrial lesions after tamoxifen therapy in breast cancer women.
    Maugeri G; Nardo LG; Campione C; Nardo F
    Breast J; 2001; 7(4):240-4. PubMed ID: 11678801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.
    Ceci O; Bettocchi S; Marello F; Nappi L; Chiechi LM; Laricchia L; Masciandaro A
    J Am Assoc Gynecol Laparosc; 2000 Feb; 7(1):77-81. PubMed ID: 10648743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
    Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
    J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
    López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
    Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment.
    Sendag F; Sahin C; Zeybek B; Terek MC; Oztekin K; Bilgin O
    Eur J Gynaecol Oncol; 2010; 31(4):415-7. PubMed ID: 20882884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
    Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
    Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
    J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
    Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
    J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
    Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
    Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and the endometrium.
    Barakat RR
    Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.
    Giorda G; Crivellari D; Veronesi A; Perin T; Campagnutta E; Carbone A; Scarabelli C
    Acta Obstet Gynecol Scand; 2002 Oct; 81(10):975-80. PubMed ID: 12366490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on postmenopausal endometrium.
    Kalampokas T; Sofoudis C; Anastasopoulos C; Boutas I; Melloy S; Kondi-Pafiti A; Kalampokas E; Botsis D; Salakos N
    Eur J Gynaecol Oncol; 2013; 34(4):325-8. PubMed ID: 24020139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
    BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tamoxifen on the endometrium.
    Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S
    Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.